Key result
Phosphatidylinositol 4,5-bisphosphate (PIP2) activates TRPC1 store-operated channels in native vascular myocytes and is obligatory for channel activation by store-depleting agents.
This preclinical study demonstrates that PIP2 plays an obligatory, PKC-dependent role in the activation of TRPC1 store-operated channels in vascular myocytes.
No immediate clinical implications; leaves open PIP2-TRPC1 targeting in human vascular disease.
In the present study the effect of phosphatidylinositol 4,5-bisphosphate (PIP(2)) was studied on a native TRPC1 store-operated channel (SOC) in freshly dispersed rabbit portal vein myocytes. Application of diC8-PIP(2), a water soluble form of PIP(2), to quiescent inside-out patches evoked single channel currents with a unitary conductance of 1.9 pS. DiC8-PIP(2)-evoked channel currents were inhibited by anti-TRPC1 antibodies and these characteristics are identical to SOCs evoked by cyclopiazonic acid (CPA) and BAPTA-AM. SOCs stimulated by CPA, BAPTA-AM and the phorbol ester phorbol 12,13-dibutyrate (PDBu) were reduced by anti-PIP(2) antibodies and by depletion of tissue PIP(2) levels by pre-treatment of preparations with wortmannin and LY294002. However, these reagents did not alter the ability of PIP(2) to activate SOCs in inside-out patches. Co-immunoprecipitation techniques demonstrated association between TRPC1 and PIP(2) at rest, which was greatly decreased by wortmannin and LY294002. Pre-treatment of cells with PDBu, which activates protein kinase C (PKC), augmented SOC activation by PIP(2) whereas the PKC inhibitor chelerythrine decreased SOC stimulation by PIP(2). Co-immunoprecipitation experiments provide evidence that PKC-dependent phosphorylation of TRPC1 occurs constitutively and was increased by CPA and PDBu but decreased by chelerythrine. These novel results show that PIP(2) can activate TRPC1 SOCs in native vascular myocytes and plays an important role in SOC activation by CPA, BAPTA-AM and PDBu. Moreover, the permissive role of PIP(2) in SOC activation requires PKC-dependent phosphorylation of TRPC1.
No takes yet. Share an insight, caveat, or question.
Saleh et al. (2008) studied Vascular smooth muscle cell physiology. diC8-PIP2 and anti-PIP2 antibodies vs. Control (absence of PIP2 or presence of inhibitors) was evaluated on Mean open probability (NPo) of SOC activity. Phosphatidylinositol 4,5-bisphosphate (PIP2) activates TRPC1 store-operated channels in native vascular myocytes and is obligatory for channel activation by store-depleting agents.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: